Figure 2.

A: Relative frequencies of recurrent segments of CNV in 168 patients with CLL versus 73 white HapMap individuals, based on their minimally deleted/gained region by SNP genotyping. Eighty-two autosomal CNVs identified as significantly more frequent in patients with CLL than in HapMap individuals are indicated in red (χ² test). Segments of CNV identified as significantly more frequent in HapMap individuals than in patients with CLL are indicated in blue. Segments identified as equally frequent in both groups are indicated in gray. B: Frequency of recurrent CLL-specific CNVs per patient. CEU, standard HapMap designation of Utah residents with Northern and Western ancestry (ie, white).